{"organizations": [], "uuid": "6d92ad72f6009258b2d0b5c8c96851983cc4b1b7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cellectar-receives-uspto-notice-of/brief-cellectar-receives-uspto-notice-of-allowance-for-patent-covering-use-of-clr-131-in-multiple-myeloma-idUSFWN1PX19S", "country": "US", "domain_rank": 408, "title": "BRIEF-Cellectar Receives USPTO Notice Of Allowance For Patent Covering Use Of CLR 131 In Multiple Myeloma", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.994, "site_type": "news", "published": "2018-02-07T21:30:00.000+02:00", "replies_count": 0, "uuid": "6d92ad72f6009258b2d0b5c8c96851983cc4b1b7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cellectar-receives-uspto-notice-of/brief-cellectar-receives-uspto-notice-of-allowance-for-patent-covering-use-of-clr-131-in-multiple-myeloma-idUSFWN1PX19S", "ord_in_thread": 0, "title": "BRIEF-Cellectar Receives USPTO Notice Of Allowance For Patent Covering Use Of CLR 131 In Multiple Myeloma", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "cellectar biosciences inc", "sentiment": "negative"}, {"name": "clr", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 7 (Reuters) - Cellectar Biosciences Inc:\n* CELLECTAR RECEIVES USPTO NOTICE OF ALLOWANCE FOR PATENT COVERING USE OF CLR 131 IN MULTIPLE MYELOMA Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-07T21:30:00.000+02:00", "crawled": "2018-02-09T06:06:02.022+02:00", "highlightTitle": ""}